MIRM

Mirum Pharmaceuticals, Inc.

29.91 USD
+1.20 (+4.18%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Mirum Pharmaceuticals, Inc. stock is up 13.04% since 30 days ago. The next earnings date is May 2, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 4 March’s closed higher than February. In the last 1 Unusual Options Trades, there were 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
09 Jan 15:20 15 Mar, 2024 25.00 PUT 4999 0

About Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease.

  • HC Wainwright & Co.
    Thu Feb 29, 15:06
    buy
    confirm
  • JP Morgan
    Thu Feb 29, 14:23
    buy
    confirm
  • Cantor Fitzgerald
    Thu Feb 29, 13:34
    buy
    confirm